Invasive Prostate Carcinoma — Trials

Invasive Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

440 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 139
Recruiting: 65
Ph III recruiting: 5
Growth YoY: —
Industry share: 4%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 31.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (72)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04097002	First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.	unknown	Phase 1 / Phase 2	24	Orca Therapeutics B.V.INDUSTRY	1	Oct 31, 2023	clinicaltrials
NCT02031328	Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer(2STAR)	unknown	Phase 1 / Phase 2	30	Sunnybrook Health Sciences CentreOTHER	1	Nov 24, 2020